Skip to main content

NCSACW Webinar Series on Opioid Use Disorders and Treatment

NCSACW developed a webinar series on medication-assisted treatment for families affected by substance use disorders, opioid use in pregnancy and treatment for Neonatal Abstinence Syndrome.

  • Resources to Support Families in Child Welfare Affected by Opioid and Other Substance Use Disorders

    This pre-recorded webinar features a variety of technical assistance resources including publications, webinars, and tools that communities can use to better serve families in child welfare affected by opioid and other substance use disorders. The intended audience for the webinar includes Policymakers, Community-Service Providers, Public Health Professionals, Healthcare Providers, Child Welfare Professionals , Substance Use Disorder Treatment Providers.


      • Katie Ryan
      • Jill Gresham

    Date: September 10, 2018

  • Part 2: Partnering to Treat Pregnant Women with Opioid Disorders: Lessons Learned from a Six Site Initiative

    The second webinar in the series, Partnering to Treat Pregnant Women with Opioid Use Disorders: Lessons Learned from a Six Site Initiative will provide an overview and share lessons from the SAMHSA-funded initiative, Substance Exposed Infants In-Depth Technical Assistance program. The webinar will feature key findings learned in Connecticut, Kentucky, Minnesota, New Jersey, Virginia and West Virginia.


      • Jean Blankenship, MSW
      • Linda Carpenter, MEd
      • Jill Gresham, MA
      • Kari Earle, MEd

    Date: September 28, 2016

  • A Framework for Intervention for Infants with Prenatal Exposure and Their Families

    The Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment and the Administration on Children, Youth and Families, Children’s Bureau, Office on Child Abuse and Neglect, in partnership with the National Center on Substance Abuse and Child Welfare present a webinar to addresses practice and policy issues for infants with prenatal exposure and their families. The webinar introduces the Five Point Framework, which identifies points of intervention for comprehensive reform to prevent prenatal exposure and respond to the needs of pregnant women, mothers, their families and infants. The five points of intervention include pre-pregnancy, prenatal, identification at birth, post-partum, and infancy and beyond.


      • Nancy K. Young, PhD
  • Medication-Assisted Treatment (MAT) Series, Part I of II: Understanding MAT for Families Affected by Substance Use Disorders

    In the first of this two-part series, presenters will provide an overview of medication-assisted treatment for various issues and explore currently available medications.


      • Nancy K. Young, PhD
      • Mark W. Parrino, MPA

    Date: July 7, 2011

  • Medication-Assisted Treatment (MAT) Series, Part II of II: Medication-Assisted Treatment During Pregnancy, Post-natal and Beyond

    The second of this two-part series will focus on the needs of pregnant women seeking medication-assisted treatment and discuss other issues in the post-natal phase and beyond.


      • Cathleen Otero, MSW, MPA
      • Karol Kaltenbach, PhD

    Date: August 4, 2011

  • Opioid Use in Pregnancy: A Community's Approach, The Children and Recovering Mothers (CHARM) Collaborative

    This discussion-format webinar centers on services provided and collaborative practice elements across systems at multiple points of intervention that benefit pregnant women with opioid dependence, their infants and families.


      • Nancy K. Young, PhD
      • Sally Borden, MEd
      • Karen Shea, MSW

    Date: September 23, 2014

  • Opioid Use, Dependency, and Treatment in Pregnancy

    This webinar features three national experts on opioid use disorders in pregnancy and discuss treatment during pregnancy, its impact on infants and innovative strategies in working with families.


      • Anne Johnston, MD
      • Hendrée E. Jones, PhD
      • Carl Seashore, MD

    Date: May 13, 2015

  • Early Identification and Treatment of Prenatally Exposed Infants

    This discussion-format webinar provides information on early identification of prenatally exposed infants at birth, definition of substance exposed infants across systems, and pharmacological and non-pharmacological treatment of infants with NAS.


      • Sharon Burke, MD
      • Malia Beckwith, MD
      • David Babitsky, MBA

    Date: September 3, 2013



Let us know how we can help out!

Back to Top